Tic Disorders

James F. Leckman*, Bradley S. Peterson, David L. Pauls

*Room I-265, Sterling Hall of Medicine
Child Study Center, Yale University
P.O. Box 207900
230 South Frontage Road
New Haven, CT 06520-7900
phone:  (203) 785-7971
fax:  (203) 785-7611
e-mail:  james.leckman@yale.edu


  1. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neuroscience 1986;9:357-381.
  2. Anderson GM, Pollak ES, Chatterjee D, Leckman JF, Riddle MA, Cohen DJ. Postmortem analyses of brain monoamines and amino acids in Tourette's syndrome: a preliminary study of subcortical regions. Arch Gen Psychiatry 1992;49:584-586.
  3. Anderson GM, Pollak ES, Chatterjee D, Leckman JF, Riddle MA, Cohen DJ. Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv Neurol 1992;58:123-33.
  4. Apter A, Pauls DL, Bleich A, Zohar AH, Kron S, Ratzoni G, Dycian A, Kotler M, Weizman A, Gadot N, et al. An epidemiologic study of Gilles de la Tourette's syndrome in Israel. Arch Gen Psychiatry 1993;50:734-738.
  5. Barr CL, Sandor P. Current status of genetic studies of Gilles de la Tourettesyndrome. Can J Psychiatry 1998;43:351-357.
  6. Baumgardner TL, Singer HS, Denckla MB, Rubin MA, Abrams MT, Colli MJ, Reiss AL. Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 1996;47:477-482.
  7. Baxter LR Jr, Schwartz JA, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, et all. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:681-689.
  8. Berthier ML, Kulisevsky J, Campos VM. Bipolar disorder in adult patients with Tourette's syndrome: a clinical study. Biol Psychiatry 1998;43:364-370.
  9. Brett PM, Curtis D, Robertson MM, Gurling HM. The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase. Biol Psychiatry 1995;37:533-540.
  10. Burd L, Kerbeshian J, Wikenheiser M, Fisher W . A prevalence study of Gilles de la Tourette syndrome in North Dakota school-age children. J Am Acad Child Adolesc Psychiatry 1986;25:552-553.
  11. Burd L, Kerbeshian J, Wikenheiser M, Fisher W. Prevalence of Gilles de la Tourette's syndrome in North Dakota adults. Am J Psychiatry 1986;143:787-788.
  12. Carter AS, Pauls DL, Leckman JF, Cohen DJ. A prospective longitudinal study of Gilles de la Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1994;33:377-385.
  13. Chappell PB, Leckman JF, Goodman WK, Bissette G, Pauls DL, Anderson GM, Riddle M, Scahill L, McDougle CJ, Cohen DJ. Elevated cerebrospinal fluid corticotopin-releasing factor in Tourette's patients: Comparison to obsessive-compulsive disorder and normal controls. Biol Psychiatry 1996;39:776-783.
  14. Chappell PB, Leckman JF, Riddle MA, Anderson GM, Listwak SJ, Ort SI, Hardin MT, Cohen DJ. Neuroendocrine and behavioral effects of naloxone in Tourette's syndrome. Adv Neurol 1992;35:253-262.
  15. Chappell PB, McSwiggan-Hardin MT, Scahill L, Rubenstein M, Walker D, Cohen DJ, Leckman JF. The role of videotape tic counts in the assessment of Tourette syndrome: Stability, reliability, and validity. J Am Acad Child Adolesc Psychiatry 1994;33:386-393.
  16. Chappell PB, Riddle M, Anderson G, Scahill L, Hardin M, Walker D, Cohen D, Leckman JF. Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture. Biol Psychiatry 1994;36:35-43.
  17. Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder in Tourette's syndrome: Preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1995; 34:1140-1146.
  18. Coffey B, Frazier J, Chen S. Comorbidity, Tourette syndrome, and anxiety disorders. Adv Neurol 1992;58:95-104.
  19. Comings DE, Comings BG. A controlled study of Tourette syndrome. Am J Hum Gen 1987;41:701-741.
  20. Comings DE, Himes JA, Comings BG. An epidemiological study of Tourette's syndrome in a single school district. J Clin Psychiatry 1990;51:463-469.
  21. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, Saucier G, Ferry L, Rosenthal RJ, Lesieur HR, Rugle LJ, MacMurray P. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 1997;2:44-56.
  22. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. Am J Med Genet 1996;67:264-288.
  23. Costello EJ, Angold A, Burns BJ, Stangl DK, Tweed DL, Erkanli A, Worthman CM. The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry 1996;53:1129-1136.
  24. Crum RM, Anthony JC. Cocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the Epidemiologic Catchment Area survey Drug Alcohol Depend 1993;31:281-295.
  25. Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome: Possible midbrain involvement. Arch Neurol 1983;40:508-514.
  26. Dykens E, Leckman JF, Riddle MA, Hardin MT, Schwartz S, Cohen DJ. Intellectual, academic, and adaptive functioning of Tourette syndrome children with and without attention deficit disorder. J Abn Child Psychol 1990;18:607-615.
  27. Eapen N, Pauls DL, Robertson MM. Evidence for autosomal dominant transmission in Gilles de la Tourette Syndrome-United Kingdom cohort study. Br J Psychiatry 1993;162:593-596.
  28. Filion M, Tremblay L. Abnormal spontaneous activity of the globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:147-151.
  29. Filion M, Tremblay L, Bédard PJ. Effects of dopamine agonists on the spontaneous activity of the globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:152-161.
  30. Flaherty AW, Graybiel AM. Two input systems for body representations in the primate striatal matrix: experimental evidence in the squirrel monkey. J Neurosci 1993;13:1120-1137.
  31. Gelernter J, Pauls DL, Leckman J, Kidd KK, Kurlan R. D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Results from four large kindreds. Arch Neurol 1994;51:397-400.
  32. Girault JA, Spampinato U, Glowinski J, Besson MJ. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum - II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen. Neuroscience 1986;19:1109-1117.
  33. Glaze DG, Frost JD, Jankovich J. Sleep in Gilles de la Tourette's syndrome: Disorder of arousal. Neurology 1983;33:586-592.
  34. Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods. Ann Neurol 1987;21:307-310.
  35. Golden GS. Gilles de la Tourette's syndrome following methylphenidate administration. Develop Med Child Neurol 1974;16:76-78.
  36. Gonce M, Barbeau A. Seven cases of Gilles de la Tourette's syndrome: Partial relief with clonazepam: A pilot study. Can J Neurol Science 1977;3: 279-283.
  37. Goodman WK, McDougle CJ, Price LH, et al. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry 1990;51:36-43.
  38. Graybiel AM. Building action repertoires: Memory and learning functions of the basal ganglia. Cur Opin Neurobiol 1995;5:733-741.
  39. Graybiel AM, Aosaki T, Flaherty AW, Kimura M. The basal ganglia and adaptive motor control. Science 1994;265:1826-1831.
  40. Grice DE, Leckman JF, Pauls DL, Kurlan R, Kidd KK, Pakstis AJ, Chang FM, Buxbaum JD, Cohen DJ, Gelernter J. Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. Am J Hum Genet 1996;59:644-652.
  41. Haber SN, Kowall N, Vonsattel J, Bird E, Richardson EJ. Gilles de la Tourette's syndrome: A postmortem neuropathological and immunohistochemical study. J Neurol Sci 1986;75:225-241.
  42. Haber SN, Wolfer D. Basal ganglia peptidergic staining in Tourette syndrome. A follow-up study. Adv Neurol 1992; 58:145-150.
  43. Hasstedt SJ, Leppert M, Filloux F, van de Wetering BJ, McMahon WM. Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet 1995;57:682-689.
  44. Hebebrand J, Nothen MM, Ziegler A, Klug B, Neidt H, Eggermann K, Lehmkuhl G, Poustka F, Schmidt MH, Propping P, Remschmidt H. Nonreplication of linkage disequilibrium between the dopamine D4 receptor locus and Tourette syndrome. Am J Hum Genet 1997;61:238-239.
  45. Hyde TM, Aaronson BA, Randloph C, Rickler KS, Weinberger DR. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 1992;42:652-658.
  46. Jadresic D. The role of the amygdaloid complex in Gilles de la Tourette's syndrome. Br J Psychiatry 1992;161:532-534.
  47. Kerbeshian J, Burd L, Klug MG. Comorbid Tourette's disorder and bipolar disorder: an etiologic perspective. Am J Psychiatry 1995;152:1646-1651.
  48. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993;92:39-43.
  49. Klawans HL, Falk DK, Nausieda PA, Weiner WJ. Gilles de la Tourette syndrome after long-term chlorpromazine therapy. Neurology 1978;28:1064-1066.
  50. Leckman JF, Cohen DJ. Tourette’s Syndrome Tics, Obsessions, Compulsions - Developmental Psychopathology and Clinical Care. New York: John Wiley and Sons, 1998.
  51. Leckman JF, Cohen DJ, Gertner JM, Ort S, Harcherik D: Growth hormone response to clonidine in children (ages 4-l7 yrs): Tourette syndrome vs. children with short stature. J Am Acad Child Psychiatry 1984;23:174-181.
  52. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, Walker DE, Scahill LD, Ort SI, Pauls DL, Cohen DJ, Price LH. CSF biogenic amines in obsessive compulsive disorder and Tourette's syndrome. Neuropsychopharmacol 1995;12:73-86.
  53. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL: Symptoms of obsessive compulsive disorder. Am J Psychiatry 1997;154:911-917.
  54. Leckman JF, Dolnansky ES, Hardin MT, Clubb M, Walkup JT, Stevenson J, Pauls DL. Perinatal factors in the expression of Tourette's syndrome: An exploratory study. J Am Acad Child Adol Psychiatry 1990;29:220-226.
  55. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ: Clonidine treatment of Tourette's syndrome. Arch Gen Psychiatry 1991; 48:324-328.
  56. Leckman JF, Knorr AM, Rasmusson AM, Cohen DJ. Basal ganglia research and Tourette's syndrome. Trends Neurosci 1991;14:94.
  57. Leckman JF, McDougle CJ, Pauls DL: Tic-related vs. non-tic related obsessive-compulsive disorder. In: Gookman WK, Mazur J (eds.), Treatment challenges in Obsessive-compulsive Disorder. New York: Lawrence Erlbaum, 1998.
  58. Leckman JF, Ort S, Cohen DJ, Caruso KA, Anderson GM, Riddle MA: Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine: Behavioral, cardiovascular, and neurochemical effects. Arch Gen Psychiatry 1986; 43:1168-1176.
  59. Leckman JF, Pauls DL, Peterson BS, Riddle MA, Anderson GM, Cohen DJ. Pathogenesis of Tourette syndrome: Clues form the clinical phenotype and natural history. Adv Neurol 1992;58:15 -24.
  60. Leckman JF, Peterson BS: The pathogenesis of Tourette's syndrome: Role of epigenetic factors active in early CNS development. Biol Psychiatry 1993;34:425-427.
  61. Leckman JF, Peterson, BS, Anderson, GM, Arnsten AF, Pauls DL Cohen DJ. Pathogenesis of Tourette’s syndrome. J Child Psychol Psychiatry 1997;38:119-142.
  62. Leckman JF, Price RA, Walkup JT, Ort S, Pauls DL, Cohen DJ. Birthweights of monozygotic twins discordant for Tourette's Syndrome. Arch Gen Psychiatry 1987;44:100.
  63. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale (YGTSS): Initial testing of a clinican-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566-573.
  64. Leckman JF, Scahill L. Possible exacerbation of tics by androgenic steroids. N Engl J Med 1990;322:1674.
  65. Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993;150:98-102.
  66. Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. "Just right" perceptions associated with compulsive behaviors in Tourette’s syndrome. Am J Psychiatry 1994;151:675-680.
  67. Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS, Peterson BS. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998;102:14-19.
  68. Lombroso PJ, Mack G, Scahill L, King R, Leckman JF. Exacerbation of Tourette's syndrome associated with thermal stress: a family study. Neurology 1991;41:1984-1987.
  69. Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis LB. [123I]Beta-CIT SPECT imaging demonstrates increased striatal dopamine transporter binding in Tourette's syndrome. Am J Psychiatry 1995;152: 1359-1361.
  70. Mason A, Banerjee S, Eapen V, Zeitlin H, Robertson MM. The prevalence of Tourette syndrome in a mainstream school population. Dev Med Child Neurol 1998;40:292-296.
  71. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive compulsive disorder: Effects of comorbid chronic tic disorder. J Clin Psychopharmacol 1993;13:354-358.
  72. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder: A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1996; 53: 1001-1008.
  73. Mesulam MM. Cocaine and Tourette's syndrome. N Engl J Med 1986;315:398.
  74. Muller N, Putz A, Klages U, Hofschuster E, Straube A, Ackenheil M. Blunted growth hormone response to clonidine in Gilles de la Tourette syndrome. Psychoneuroendocrinology 1994;19:335-341.
  75. Murphy TK, Goodman WK, Fudge MW, Williams RC Jr, Ayoub EM, Dalal M, Lewis MH, Zabriskie JB. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry 1997;154:402-407.
  76. Nothen MM, Hebebrand J, Knapp M, Hebebrand K, Camps A, von Gontard A, Wettke-Schafer R, Lisch S, Cichon S, Poustka F, et al. Association analysis of the dopamine D2 receptor gene in Tourette's syndrome using the haplotype relative risk method. Am J Med Genet 1994;54:249-252.
  77. Pasamanick B, Kawai A: A study of the association of prenatal and paranatal factors with the development of tics in children. Pediatrics 1956;48:596-601.
  78. Pauls DL, Alsobrook JP 2nd, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.
  79. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette syndrome and associated behaviors: Evidence for an autosomal dominant transmission. N Engl J Med 1986; 315:993-997.
  80. Pauls DL, Leckman JF, Cohen DJ. The familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 1993;32:1044-1050.
  81. Peterson BS, Leckman JF. Temporal characterization of tics in Gilles de la Tourette's syndrome. Biol Psychiatry, in press.
  82. Peterson BS, Leckman JF, Duncan J, Wetzels R, et al. Corpus callosum morphology from MR images in Tourette's syndrome. Psych Res 1994;55:85-99.
  83. Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ, Cohen DJ. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinol 1992;17:553-563.
  84. Peterson BS, Riddle MA, Cohen DJ, Katz LD, Smith JC, Hardin MT, Leckman JF. Reduced basal ganglia volumes in Tourette's syndrome using 3-dimensional reconstruction techniques from magnetic resonance images. Neurology 1993;43:941-949.
  85. Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM, Leckman JF, Gore JC. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 1998;55:326-333.
  86. Peterson BS, Zhang H, Anderson GM, Leckman JF. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome. J Clin Psychopharmacol 1998;18:324-331.
  87. Price AR, Kidd KK, Cohen DJ, Pauls DL, Leckman JF. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985;42:815-82.
  88. Robertson MM, Channon S, Baker J, Flynn D. The psychopathology of Gilles de la Tourette's syndrome. A controlled study. Br J Psychiatry 1993;162:114-117.
  89. Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997;154:1057-1062.
  90. Sanberg PR, Silver AA, Shytle RD, Philipp MK, Cahill DW, Fogelson HM, McConville BJ. Nicotine for the treatment of Tourette's syndrome. Pharmacol Ther 1997;74:21-25.
  91. Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW, Leckman JF. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 1997;7:75-85.
  92. Schwartz JM. Obsessive-compulsive disorder. Science Med 1997;4:14-23.
  93. Shapiro AK, Shapiro ES, Young JG, Feinberg T. Gilles de la Tourette Syndrome (Second ed.). New York: Raven Press, 1988.
  94. Shapiro ES, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989;46:722-730.
  95. Sikich L, Todd RD. Are neurodevelopmental effects of gonadal hormones related to sex differences in psychiatric illnesses. Psychiat Develop 1988;6:277-310.
  96. Silva RR, Munoz DM, Barickman J, Friedhoff AJ. Environmental factors and related fluctuation of symptoms in children and adolescents with Tourette's disorder. J Child Psychol Psychiatry 1995;36:305-312.
  97. Singer HS. Neurobiology of Tourette syndrome. Neurol Clin 1997;15:357-379.
  98. Singer HS, Giuliano JD, Hansen BH, Hallett JJ, Laurino JP, Benson M, Kiessling LS. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998;50:1618-1624.
  99. Singer HS, Hahn I-H, Krowiak E, Moran TH. Neurochemical analysis of postmortem cortical and striatal brain tissue in patients with Tourette syndrome. Adv Neurol 1992;58:135-144.
  100. Singer HS, Hahn I-H, Moran TH. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 1991;30:558-562.
  101. Singer HS, Oshida L, Coyle JT. CSF cholinesterase activity in Gilles de la Tourette's syndrome. Arch Neurol 1984l;41:756-757.
  102. Singer HS, Reiss AL, Brown JB, Aylward EH, Shih B, Chee E, Harris EL, Reader MJ, Chase GA, Bryan RN, et al. Volumetric MRI changes in basal ganglia of children with Tourette syndrome. Neurology 1993;43:950-956.
  103. Stahl SM, Berger PA. Physostigmine in Tourette syndrome: evidence for cholinergic underactivity. Am J Psychiatry 1981;138:240-242.
  104. Stoetter B, Braun AR, Randolph C, et al. Functional neuroanatomy of Tourette Syndrome: limbic-motor interactions studied with FDG PET. In: Chase TN, Friedhoff AJ, Cohen DJ, eds. Advances in Neurology. Vol. 58. New York: Raven Press, 1992;213-226.
  105. Stokes A, Bawden HN, Camfield PR, Backman JE, Dooley MB. Peer problems in Tourette's disorder. Pediatrics 1991;87:936-942.
  106. Swedo SE, Kilpatrick K, Schapiro MB, Mannheim GB, Leonard HL. Antineuronal antibodies in Sydenham's chorea and obsessive compulsive disorder. Pediatric Research 1991;29:369a.
  107. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinicaldescription of the first 50 cases. Am J Psychiatry 1998;155:264-271.
  108. Swedo SE, Leonard HL, Mittleman BB, Allen AJ, Rapoport JL, Dow SP, Kanter ME, Chapman F, Zabriskie J. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997;154:110-112.
  109. Swedo SE, Leonard HL, Schapiro MB, Casey BJ, Mannheim GB, Lenane MC, Rettew DC. Sydenham's chorea: Physical and psychological symptoms of St Vitus Dance. Pediatrics 1993; 91;706-713.
  110. Sweet RD, Bruun R, Shapiro E, Shapiro AK. Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine. Arch Gen Psychiatry 1974;31:857-861.
  111. Tanner CM, Goetz CG, Klawans HL. Cholinergic mechanisms in Tourette syndrome. Neurology 1982;32:1315-1317.
  112. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 1996;59:684-693.
  113. Walkup JT, Leckman JF, Price AR, Hardin M, Ort SI, Cohen DJ. The relationship between obsessive compulsive disorder and Tourette's syndrome. Psychopharmacol Bull 1988;24:375-379.
  114. Whitaker AH, Van Rossem R, Feldman JF, Schonfeld IS, Pinto-Martin JA, Tore C, Shaffer D, Paneth N.Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities. Arch Gen Psychiatry 1997;54:847-856.
  115. Wolf SS, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM, Coppola R, Weinberger DR. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996;273: 1225-1227.
  116. Wong DF, Singer HS, Brandt J, Shaya E, Chen C, Brown J, Kimball AW, Gjedde A, Dannals RF, Ravert HT, Wilson PD, Wagner HN Jr. D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 1997;38:1243-1247.
  117. Wong DF, Ricaurte G, Grunder G, Rothman R, Naidu S, Singer H, Harris J, Yokoi F, Villemagne V, Szymanski S, Gjedde A, Kuhar M. Dopamine transporter changes in neuropsychiatric disorders. Adv Pharmacol 1998;42:219-223
  118. Zametkin AJ, Liotta W. The neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 1998;59 Suppl 7:17-23.
  119. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323:1361-1366.

Back to Chapter

published 2000